🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, assessor blind, parallel group, three arms, active and placeb...
Status
Unknown
Location
Lotus Multispeciality Hospital
Start Date
2022-01-24
Trial ID
NCT05249972
4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to p...
Status
Recruiting
Location
Psoriasis Treatment Center of Central New Jersey
Start Date
2019-01-16
Trial ID
NCT03827876
Treatments Being Tested
Psoriasis is a non-communicable chronic immune-mediated disease. Psoriatic ...
Status
Active Not Recruiting
Location
Department of Dermatology
Start Date
2022-02-16
Trial ID
NCT05185258
Treatments Being Tested
The aim of the study is to evaluate the efficacy and safety of Enstilar Foa...
Status
Completed
Location
The University of Alabama at Birmingham
Start Date
2021-11-01
Trial ID
NCT04227288
Treatments Being Tested
Add-on Enstilar to Otezla therapy....
Status
Completed
Location
Psoriasis Treatment Center of Central New Jersey
Start Date
2018-07-23
Trial ID
NCT03587194
Treatments Being Tested
The trial is conducted to investigate the clinical efficacy of a combinatio...
Status
Completed
Location
Bispebjerg Hospital
Start Date
2020-10-02
Trial ID
NCT04580537
Treatments Being Tested
Observational, prospective and multicentre study to evaluate the effectiven...
Status
Completed
Location
Complejo Hospitalario Universitario de Pontevedra
Start Date
2019-03-26
Trial ID
NCT04380597
Treatments Being Tested
This study seeks to show whether there is a benefit of prescribing Enstilar...
Status
Completed
Location
Center for Dermatology and Laser Surgery
Start Date
2017-09-18
Trial ID
NCT03441789
The primary objective is to assess with the PPQ questionnaire the patient p...
Status
Completed
Location
Policlinico Agostino Gemelli
Start Date
2024-01-01
Trial ID
NCT06180473
Treatments Being Tested
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, ...
Status
Completed
Location
Investigational Site 20
Start Date
2018-10-31
Trial ID
NCT03731091